Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | DIVIT NUTRACEUTICALS PRIVATE LIMITED | 1 | ₹9,600 |
| 2 | Schedule 2 | SUNIL PHARMACY | 1 | ₹290 |
| 3 | Schedule 3 | M/S TRIPTI MEDICAL AGENCY | 1 | ₹4,524 |
| 4 | Schedule 4 | MEDICARES | 1 | ₹1,008 |
| 5 | Schedule 5 | FASTCARE PHARMA | 7 | ₹3,488 |
Tender Value
₹99,067
EMD Value
Exempted
Closing Date
31 Oct 2025, 11:00 amClosed
E CFA RE 06 Acetylcysteine 300Mg PLUSPyridoxamine Dihydrochloride 50Mg Tab
E CFA RE 06 Bisacodyl 10 Mg Tab
E CFA RE 06 Entecavir 0DOT5 Mg Tab
E CFA RE 06 Escitalopram 5 Mg Tab
E CFA RE 06 Esomeprazole 20 Mg PLUS Domperidone 30 Mg Tab
E CFA RE 06 Etodolac 300Mg Tab
E CFA RE 06 Etodolac 400 Mg Tab
E CFA RE 06 Evening Primrose 500 Mg Tab
E CFA RE 06 Evening Promise 1000 Cap
E CFA RE 06 Ezetimibe 10 Mg Tab
E CFA RE 06 Ezetimibe 10mg PLUS Atorvastatin 10 mgTab
E CFA RE 06 Fexofenadine 120 Mg PLUSMontelukast 10Mg Tab
E CFA RE 06 Flavoxate 200Mg Tab
E CFA RE 06 Flunarizine 10 Mg Tab
E CFA RE 06 Fluoxetine 20 Mg Tab
E CFA RE 06 Flupentixol 0DOT5 Mg PLUS Melitracen 10 Mg Tab
E CFA RE 06 Fluvoxamine 50 Mg Tab
E CFA RE 06 Frusemide 40 Mg Lasix Tab
E CFA RE 06 Gabapentin 100Mg Tab
E CFA RE 06 Gabapentin 300 Mg PLUS Methylcobalamin 500 Mg Tab
E CFA RE 06 Gabapentin 300Mg PLUS Methylcobalamin 1500 Mcg Tab
E CFA RE 06 Ginkgo Biloba 40 mgTab
E CFA RE 06 Gliclazide 30 Mg Mr Tab
E CFA RE 06 Gliclazide 80 Mg Tab
E CFA RE 06 Glimepiride 2Mg PLUS Metformin 500Mg Tab Bid Number : GEM/2025/B/6809822 Dated : 21-10-2025 Bid Document 1/25
8495278
GEM/2025/B/6809822
Two Packet Bid
E CFA RE 06 Acetylcysteine 300Mg PLUSPyridoxamine
30 days
DARJEELING
Item wise evaluation
BOQ
8 documents required · 8 mandatory
3 yrs
₹31
₹1 L
80%
Exempted
31 Oct 2025
21 Oct 2025
31 Oct 2025
Drugs and Pharamceutical Products
E CFA RE 06 Acetylcysteine 300Mg PLUSPyridoxamine Dihydrochloride 50Mg Tab
E CFA RE 06 Bisacodyl 10 Mg Tab
E CFA RE 06 Entecavir 0DOT5 Mg Tab
E CFA RE 06 Escitalopram 5 Mg Tab
E CFA RE 06 Esomeprazole 20 Mg PLUS Domperidone 30 Mg Tab
E CFA RE 06 Etodolac 300Mg Tab
E CFA RE 06 Etodolac 400 Mg Tab
E CFA RE 06 Evening Primrose 500 Mg Tab
E CFA RE 06 Evening Promise 1000 Cap
E CFA RE 06 Ezetimibe 10 Mg Tab
E CFA RE 06 Ezetimibe 10mg PLUS Atorvastatin 10 mgTab
E CFA RE 06 Fexofenadine 120 Mg PLUSMontelukast 10Mg Tab
E CFA RE 06 Flavoxate 200Mg Tab
E CFA RE 06 Flunarizine 10 Mg Tab
E CFA RE 06 Fluoxetine 20 Mg Tab
E CFA RE 06 Flupentixol 0DOT5 Mg PLUS Melitracen 10 Mg Tab
E CFA RE 06 Fluvoxamine 50 Mg Tab
E CFA RE 06 Frusemide 40 Mg Lasix Tab
E CFA RE 06 Gabapentin 100Mg Tab
E CFA RE 06 Gabapentin 300 Mg PLUS Methylcobalamin 500 Mg Tab
E CFA RE 06 Gabapentin 300Mg PLUS Methylcobalamin 1500 Mcg Tab
E CFA RE 06 Ginkgo Biloba 40 mgTab
E CFA RE 06 Gliclazide 30 Mg Mr Tab
E CFA RE 06 Gliclazide 80 Mg Tab
E CFA RE 06 Glimepiride 2Mg PLUS Metformin 500Mg Tab
Acetylcysteine 300Mg +Pyridoxamine Dihydrochloride 50Mg Tab
Bisacodyl 10 Mg Tab
Entecavir 0.5 Mg Tab
Escitalopram 5 Mg Tab
Esomeprazole 20 Mg + Domperidone 30 Mg Tab
Etodolac 300Mg Tab
Etodolac 400 Mg Tab
Evening Primrose 500 Mg Tab
Evening Promise 1000 Cap
Ezetimibe 10 Mg Tab
Ezetimibe 10mg + Atorvastatin 10 mgTab
Fexofenadine 120 Mg +Montelukast 10Mg Tab
Flavoxate 200Mg Tab
Flunarizine 10 Mg Tab
Fluoxetine 20 Mg Tab
Flupentixol 0.5 Mg + Melitracen 10 Mg Tab
Fluvoxamine 50 Mg Tab
Frusemide 40 Mg (Lasix) Tab
Gabapentin 100Mg Tab
Gabapentin 300 Mg + Methylcobalamin 500 Mg Tab
Gabapentin 300Mg + Methylcobalamin 1500 Mcg Tab
Ginkgo Biloba 40 mgTab
Gliclazide 30 Mg Mr Tab
Gliclazide 80 Mg Tab
Glimepiride (2Mg) + Metformin (500Mg) Tab
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8495278.pdf
GEM_BID
1761023514.xlsx
OTHER
DOCUMENTS_7c081b28-f295-494b-bc181761023817028_vivek2022.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
pdf_re-06_2025-10-21-10-35-55_80d64dc9cb2042c94315d54b9af7b101.pdf
BOQ
boq_item_sample_file_2025-10-21-10-35-55_732a94177a0110297d7f1382e25d5099.csv.pdf
BOQ
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .